Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Settlement is final.

I see what you're saying, but in your example, it's still ultimately a financial result from a deal announced prior to Jan '08, regardless of whether the result came in Dec '07 or Dec '09. I don't know why Goerner/PTSC would say fully reflected financial results if this were the case. It would seem more clear to say fully reflects the license fees received from those deals, thus leaving your example unambiguously in play. If the wording was as careful as implied by the company, it would seem to me that if your example is correct, the company is purposefully obfuscating the possiblity, which IMO opens them up to liability from shareholders.

Ultimately though, I hope you are correct.

Share
New Message
Please login to post a reply